Patents by Inventor Pascal Chartrand

Pascal Chartrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10092574
    Abstract: Compounds which inhibit the formation and/or accumulation of RNA foci, such as those due to polynucleotide repeats (e.g., trinucleotide repeats) are described herein. Also described herein are uses of such compounds, such as for the inhibition of the formation and accumulation such RNA foci, as well as for the treatment of polynucleotide repeat disorders (e.g., trinucleotide repeat disorders), such as myotonic dystrophy (e.g., DM1). Such compounds include compounds of formula 1, 1a, 1b, 2, 2a and (3) described herein.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: October 9, 2018
    Assignee: VALORISATION-RECHERCHE, LIMITED PARTNERSHIP
    Inventors: Pascal Chartrand, Emmanuelle Querido
  • Publication number: 20160213679
    Abstract: Compounds which inhibit the formation and/or accumulation of RNA foci, such as those due to polynucleotide repeats (e.g., trinucleotide repeats) are described herein. Also described herein are uses of such compounds, such as for the inhibition of the formation and accumulation such RNA foci, as well as for the treatment of polynucleotide repeat disorders (e.g., trinucleotide repeat disorders), such as myotonic dystrophy (e.g., DM1). Such compounds include compounds of formula 1, 1a, 1b, 2, 2a and (3) described herein.
    Type: Application
    Filed: September 25, 2013
    Publication date: July 28, 2016
    Inventors: PASCAL CHARTRAND, EMMANUELLE QUERIDO
  • Patent number: 6159714
    Abstract: Nucleic acid able to cause specific cleavage of a bond between two ribonucleotides in an RNA-containing molecule. The RNA-containing molecule has the structure:5'-XnUHZCUGANGAGYm-3'wherein each X and Y is independently any nucleotide base; n and m are independently between 5 and 40; H is U, A or C; Z is a hairpin loop, having between 6 and 60 bases, and each U, C, G and A is a uracil, cytosine, guanosine, or adenosine-containing ribonucleotide, respectively, and N is any ribonucleotide. The nucleic acid has the structure:3'-X'nM.sub.o Y'm-5'wherein each X' and Y' are complementary nucleotide bases to each corresponding X and Y, and M.sub.o is a series of nucleotide bases active to cause the cleavage, and wherein M.sub.o contains no ribonucleotides.
    Type: Grant
    Filed: March 12, 1998
    Date of Patent: December 12, 2000
    Assignee: Ribozyme Pharmacueticals, Inc.
    Inventors: Nassim Usman, Robert J. Cedergren, Pascal Chartrand, Stephen C. Harvey
  • Patent number: 5861288
    Abstract: Nucleic acid able to cause specific cleavage of a bond between two ribonucleotides in an RNA-containing molecule. The RNA-containing molecule has the structure:5'-XnUHZCUGANGAGYm-3'wherein each X and Y is independently any nucleotide base; n and m are independently between 5 and 40; H is U, A or C; Z is a hairpin loop, having between 6 and 60 bases, and each U, C, G and A is a uracil, cytosine, guanosine, or adenosine-containing ribonucleotide, respectively, and N is any ribonucleotide. The nucleic acid has the structure:3'-X'nM.sub.0 Y'm-5'wherein each X' and Y' are complementary nucleotide bases to each corresponding X and Y, and M.sub.0 is a series of nucleotide bases active to cause the cleavage, and wherein M.sub.0 contains no ribonucleotides.
    Type: Grant
    Filed: October 18, 1993
    Date of Patent: January 19, 1999
    Assignees: Ribozyme Pharmaceuticals, Inc., UAB Research Foundation, University of Montreal
    Inventors: Nassim Usman, Robert J. Cedergren, Pascal Chartrand, Stephen C. Harvey